DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction.
Authors
Hartley, John ABerardini, M
Ponti, M
Gibson, N W
Thompson, A S
Thurston, D E
Hoey, Brigid M
Butler, John
Affiliation
Department of Oncology, University College and Middlesex School of Medicine, London, U.K.Issue Date
1991-12-17
Metadata
Show full item recordAbstract
Several bifunctional alkylating agents of the aziridinylbenzoquinone class have been evaluated as potential antitumor agents. 3,6-Bis[(2-hydroxyethyl)amino]-2,5- diaziridinyl-1,4-benzoquinone (BZQ), 2,5-diaziridinyl-1,4-benzoquinone (DZQ), 3,6-bis(carboxyamino)-2,5-diaziridinyl- 1,4-benzoquinone (AZQ), and six analogues of AZQ have been studied for their ability to induce DNA interstrand cross-linking, as measured by an agarose gel technique, and to determine whether they react with DNA in a sequence-selective manner, as determined by a modified DNA sequencing technique. At an equimolar concentration (10 microM), only DZQ and BZQ showed any detectable cross-linking at pH 7 without reduction. Cross-linking was enhanced in both cases at low pH (4). Reduction by ascorbic acid at both pH's increased the cross-linking, which was particularly striking in the case of DZQ. In contrast, AZQ and its analogues only produced a significant level of cross-linking under both low-pH and reducing conditions, the extent of cross-linking decreasing as the size of the alkyl end group increased. The compounds reacted with all guanine-N7 positions in DNA with a sequence selectivity similar to other chemotherapeutic alkylating agents, such as the nitrogen mustards, although some small differences were observed with BZQ. Nonreduced DZQ showed a qualitatively similar pattern of reactivity to the other compounds, but on reduction (at pH 4 or 7) was found to react almost exclusively with 5'-GC-3' sequences, and in particular, at 5'-TGC-3' sites. A model to explain this unique reaction is proposed.Citation
DNA cross-linking and sequence selectivity of aziridinylbenzoquinones: a unique reaction at 5'-GC-3' sequences with 2,5-diaziridinyl-1,4-benzoquinone upon reduction. 1991, 30 (50):11719-24 BiochemistryJournal
BiochemistryDOI
10.1021/bi00114a016PubMed ID
1751490Type
ArticleLanguage
enISSN
0006-2960ae974a485f413a2113503eed53cd6c53
10.1021/bi00114a016
Scopus Count
Collections
Related articles
- Alteration in DNA cross-linking and sequence selectivity of a series of aziridinylbenzoquinones after enzymatic reduction by DT-diaphorase.
- Authors: Lee CS, Hartley JA, Berardini MD, Butler J, Siegel D, Ross D, Gibson NW
- Issue date: 1992 Mar 24
- Two structurally related diaziridinylbenzoquinones preferentially cross-link DNA at different sites upon reduction with DT-diaphorase.
- Authors: Berardini MD, Souhami RL, Lee CS, Gibson NW, Butler J, Hartley JA
- Issue date: 1993 Apr 6
- Alkylation of DNA by the new anticancer agent 3,6-diaziridinyl-2,5-bis(carboethoxyamino)-1,4-benzoquinone (AZQ).
- Authors: King CL, Wong SK, Loo TL
- Issue date: 1984 Feb
- Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity.
- Authors: Gibson NW, Hartley JA, Butler J, Siegel D, Ross D
- Issue date: 1992 Sep
- Cross-linking and sequence specific alkylation of DNA by aziridinyl quinones. 2. Structure requirements for sequence selectivity.
- Authors: Hargreaves RH, Mayalarp SP, Butler J, McAdam SR, O'Hare CC, Hartley JA
- Issue date: 1997 Jan 31